Evidence map›Paper›PMID 41601185›Full record

ArticleAmerican journal of Alzheimer's disease and other dementias

Construction and Interpretability of a Multimodal Deep Learning Model of Electronystagmography-Optical Coherence Tomography Angiography for Early Screening of Alzheimer's Disease.

Zhuoying Zhu, Xiaoling Zhang, Congying Xu, Yufei Shen

Abstract readValidation Study
In one paragraph

Article in American journal of Alzheimer's disease and other dementias. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhuoying ZhuDepartment of Neurology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.
Xiaoling ZhangDepartment of Neurology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.
Congying XuDepartment of Neurology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.
Yufei ShenDepartment of Neurology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.ORCID 0009-0007-4857-8070

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to explore the value and interpretability of a multimodal deep learning model integrating optical coherence tomography angiography (OCTA) and electronystagmography (ENG) for the early screening of Alzheimer's disease (AD) and mild cognitive impairment (MCI). A total of 250 subjects were retrospectively recruited. OCTA images, ENG signals and neurocognitive scores were collected from all subjects. The model had an area under curve of 0.85 for the independent validation cohort, with the sensitivity and specificity of 0.73 and 0.90 at the optimal cut-off of receiver operating characteristic curve, respectively. According to Gradient-weighted Class Activation Mapping analysis, the model focused on regions with reduced microvascular density. SHapley Additive exPlanations analysis revealed that saccade accuracy (left eye), saccade latency (right eye) and smooth pursuit gain (left eye) contributed the most to the model. The multimodal model effectively improves early, non-invasive screening of AD/MCI with good interpretability.

Indexed as

Alzheimer DiseaseAngiographyCognitive DysfunctionDeep LearningElectronystagmographyTomography, Optical CoherenceAgedArea Under CurveCross-Sectional StudiesEarly DiagnosisFemaleHumansMaleMiddle AgedMultimodal ImagingReference ValuesAlzheimer’s diseasecognitive impairmentdeep learningelectronystagmographyinterpretability

Identifiers

PMID41601185
PMCPMC12852582

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.